Fatal acute undifferentiated febrile illness among clinically suspected leptospirosis cases in Colombia, 2016-2019.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 10 02 2023
accepted: 26 09 2023
revised: 26 10 2023
medline: 30 10 2023
pubmed: 16 10 2023
entrez: 16 10 2023
Statut: epublish

Résumé

Acute undifferentiated febrile illness is a common challenge for clinicians, especially in tropical and subtropical countries. Incorrect or delayed diagnosis of febrile patients may result in medical complications or preventable deaths. Common causes of acute undifferentiated febrile illness in Colombia include leptospirosis, rickettsioses, dengue fever, malaria, chikungunya, and Zika virus infection. In this study, we described the acute undifferentiated febrile illness in postmortem patients reported as suspected cases of leptospirosis through the national leptospirosis surveillance in Colombia, 2016-2019. We retrospectively analyze human fresh and formalin-fixed tissue samples from fatal suspected leptospirosis cases reported by the Public Health Laboratories in Colombia. Leptospirosis confirmation was made by immunohistochemistry, real-time polymerase chain reaction (PCR) in the tissue samples. In some cases, the serum sample was used for confirmation by Microagglutination test (MAT). Simultaneously, tissue samples were tested by PCR for the most common viral (dengue, Zika, and chikungunya), bacterial (Brucella spp., and Rickettsia spp.), and parasitic (malaria). Fresh tissue samples from 92 fatal suspected leptospirosis cases were reported to the National Reference Laboratory from 22/32 departments in Colombia. We confirmed leptospirosis in 27% (25/92) of cases. Other pathogens identified by real-time PCR were Brucella spp. (10.9%), Rickettsia spp. (14.1%), and dengue (2.2%). Dengue (6.9%), hepatitis (3.5%), and Yellow Fever cases (2.2%) were detected by the pathology. All patients were negative for chikungunya and Plasmodium spp. Most cases were classified as undifferentiated febrile illnesses (45.7%; 42/92). This study underscores the importance of early and accurate recognition of leptospirosis to prevent mortalities. Moreover, it draws attention to the existence of other febrile syndromes in Colombia, including rickettsiosis and brucellosis, that currently lack sufficient human surveillance and regular reporting. Expanding laboratory surveillance to include viruses such as Hantavirus, Mayaro virus, Oropouche virus, and West Nile virus is crucial.

Sections du résumé

BACKGROUND BACKGROUND
Acute undifferentiated febrile illness is a common challenge for clinicians, especially in tropical and subtropical countries. Incorrect or delayed diagnosis of febrile patients may result in medical complications or preventable deaths. Common causes of acute undifferentiated febrile illness in Colombia include leptospirosis, rickettsioses, dengue fever, malaria, chikungunya, and Zika virus infection. In this study, we described the acute undifferentiated febrile illness in postmortem patients reported as suspected cases of leptospirosis through the national leptospirosis surveillance in Colombia, 2016-2019.
METHODOLOGY/PRINCIPAL FINDINGS RESULTS
We retrospectively analyze human fresh and formalin-fixed tissue samples from fatal suspected leptospirosis cases reported by the Public Health Laboratories in Colombia. Leptospirosis confirmation was made by immunohistochemistry, real-time polymerase chain reaction (PCR) in the tissue samples. In some cases, the serum sample was used for confirmation by Microagglutination test (MAT). Simultaneously, tissue samples were tested by PCR for the most common viral (dengue, Zika, and chikungunya), bacterial (Brucella spp., and Rickettsia spp.), and parasitic (malaria). Fresh tissue samples from 92 fatal suspected leptospirosis cases were reported to the National Reference Laboratory from 22/32 departments in Colombia. We confirmed leptospirosis in 27% (25/92) of cases. Other pathogens identified by real-time PCR were Brucella spp. (10.9%), Rickettsia spp. (14.1%), and dengue (2.2%). Dengue (6.9%), hepatitis (3.5%), and Yellow Fever cases (2.2%) were detected by the pathology. All patients were negative for chikungunya and Plasmodium spp. Most cases were classified as undifferentiated febrile illnesses (45.7%; 42/92).
CONCLUSIONS/SIGNIFICANCE CONCLUSIONS
This study underscores the importance of early and accurate recognition of leptospirosis to prevent mortalities. Moreover, it draws attention to the existence of other febrile syndromes in Colombia, including rickettsiosis and brucellosis, that currently lack sufficient human surveillance and regular reporting. Expanding laboratory surveillance to include viruses such as Hantavirus, Mayaro virus, Oropouche virus, and West Nile virus is crucial.

Identifiants

pubmed: 37844106
doi: 10.1371/journal.pntd.0011683
pii: PNTD-D-23-00177
pmc: PMC10602388
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0011683

Informations de copyright

Copyright: © 2023 Parra Barrera et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Clin Microbiol. 2013 Jan;51(1):314-7
pubmed: 23135935
Malar J. 2014 May 29;13:202
pubmed: 24885393
PLoS Negl Trop Dis. 2012;6(12):e1929
pubmed: 23236528
Mol Biochem Parasitol. 1993 Oct;61(2):315-20
pubmed: 8264734
BMC Infect Dis. 2019 Jul 4;19(1):577
pubmed: 31272417
Clin Microbiol Infect. 2018 Aug;24(8):808-814
pubmed: 29454844
BMC Infect Dis. 2020 Jan 30;20(1):89
pubmed: 32000695
Lancet. 2005 Dec 17;366(9503):2142-5
pubmed: 16360795
Int J Infect Dis. 2008 Jul;12(4):351-7
pubmed: 18055245
PLoS Negl Trop Dis. 2012;6(10):e1865
pubmed: 23145195
N Engl J Med. 2020 Aug 6;383(6):e44
pubmed: 27305043
PLoS One. 2015 Jun 30;10(6):e0127962
pubmed: 26126200
J Clin Microbiol. 2012 Jun;50(6):2173-5
pubmed: 22495564
Nat Commun. 2018 Apr 11;9(1):1391
pubmed: 29643334
Rev Soc Bras Med Trop. 2022 Apr 29;55:e05592021
pubmed: 35522810
Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Oct;32(10):1018-21
pubmed: 22333087
BMC Infect Dis. 2010 Apr 20;10:100
pubmed: 20403208
Curr Infect Dis Rep. 2006 Jan;8(1):51-8
pubmed: 16448601
Mem Inst Oswaldo Cruz. 2011 Feb;106(1):117-8
pubmed: 21340366
Biomedica. 2013 Sep;33 Suppl 1:153-60
pubmed: 24652259
Ticks Tick Borne Dis. 2019 Aug;10(5):995-996
pubmed: 31151921
PLoS Negl Trop Dis. 2010 Feb 23;4(2):e612
pubmed: 20186328
N Engl J Med. 2017 Feb 9;376(6):548-560
pubmed: 28177860
BMJ Case Rep. 2019 Jan 10;12(1):
pubmed: 30635303
Emerg Infect Dis. 2007 Jul;13(7):1058-60
pubmed: 18214179
Lancet Infect Dis. 2006 Feb;6(2):91-9
pubmed: 16439329
Rev Salud Publica (Bogota). 2014 Jul-Aug;16(4):597-609
pubmed: 25791310
BMJ Glob Health. 2018 Jan 4;3(Suppl 1):e000530
pubmed: 29435366
Rev Inst Med Trop Sao Paulo. 2014 Sep-Oct;56(5):411-5
pubmed: 25229221
PLoS Curr. 2017 Nov 13;9:
pubmed: 29263941
IDCases. 2016 Jun 22;5:12-4
pubmed: 27413690
Lancet. 1996 Feb 24;347(9000):535-6
pubmed: 8596276
Int J Infect Dis. 2016 Mar;44:44-9
pubmed: 26836763
Vet Microbiol. 2002 Dec 20;90(1-4):55-62
pubmed: 12414134
PLoS One. 2009 Sep 18;4(9):e7093
pubmed: 19763264
J Infect Dev Ctries. 2014 Mar 13;8(3):258-64
pubmed: 24619254
Clin Microbiol Rev. 2001 Apr;14(2):296-326
pubmed: 11292640
Lancet Infect Dis. 2003 Dec;3(12):757-71
pubmed: 14652202
Acta Med Iran. 2016 Nov;54(11):750-753
pubmed: 28033700
Clin Microbiol Infect. 2018 Aug;24(8):827-835
pubmed: 29777926
PLoS Negl Trop Dis. 2015 Mar 19;9(3):e0003499
pubmed: 25790245
Am J Trop Med Hyg. 2014 Oct;91(4):760-5
pubmed: 25092820
Am J Trop Med Hyg. 2017 Oct;97(4):1085-1087
pubmed: 28722594
Indian Heart J. 2013 Jan-Feb;65(1):72-7
pubmed: 23438616
PLoS Negl Trop Dis. 2010 Mar 16;4(3):e633
pubmed: 20300515
Emerg Infect Dis. 2020 Dec;26(12):3048-3050
pubmed: 33219809
Am J Trop Med Hyg. 2016 May 4;94(5):1065-1072
pubmed: 26928834
J Med Case Rep. 2018 Mar 9;12(1):62
pubmed: 29519244
Trop Med Infect Dis. 2018 Nov 26;3(4):
pubmed: 30486238
PLoS Negl Trop Dis. 2016 Feb 25;10(2):e0004482
pubmed: 26914210
Am J Trop Med Hyg. 2000 Nov-Dec;63(5-6):249-54
pubmed: 11421372
MMWR Morb Mortal Wkly Rep. 2012 Jun 8;61(22):421
pubmed: 22672978
PLoS Negl Trop Dis. 2015 Oct 02;9(10):e0004122
pubmed: 26431366
Epidemiol Infect. 2008 Apr;136(4):496-503
pubmed: 17559694
PLoS Negl Trop Dis. 2015 Jun 25;9(6):e0003866
pubmed: 26110270
Emerg Infect Dis. 2012 May;18(5):878-80
pubmed: 22516301
PLoS Negl Trop Dis. 2015 Sep 17;9(9):e0003898
pubmed: 26379143
Biomedica. 2021 Jun 29;41(2):208-217
pubmed: 34214261
J Infect Public Health. 2017 Sep - Oct;10(5):507-512
pubmed: 28162961
Diagn Microbiol Infect Dis. 2015 Jul;82(3):199-200
pubmed: 25912810
Lancet Infect Dis. 2007 Dec;7(12):775-86
pubmed: 18045560
Vector Borne Zoonotic Dis. 2016 Feb;16(2):85-7
pubmed: 26789730
Res Microbiol. 2003 Oct;154(8):581-6
pubmed: 14527659
Am J Trop Med Hyg. 2007 Dec;77(6):1120-3
pubmed: 18165533
PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005424
pubmed: 28771480
Am J Trop Med Hyg. 1999 Apr;60(4):687-92
pubmed: 10348249
Lancet Infect Dis. 2020 Feb;20(2):e27-e37
pubmed: 32006517
PLoS Negl Trop Dis. 2015 Dec 03;9(12):e0004040
pubmed: 26633014
PLoS One. 2018 Aug 29;13(8):e0203090
pubmed: 30157270
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Saudi J Gastroenterol. 2010 Oct-Dec;16(4):299-301
pubmed: 20871199
Biomedica. 2013 Sep;33 Suppl 1:99-107
pubmed: 24652254
Front Vet Sci. 2019 Sep 24;6:321
pubmed: 31616678

Auteurs

Eliana L Parra Barrera (EL)

Grupo de Microbiología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Grupo de Virología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Jhonatan Reales-González (J)

Grupo de Microbiología, Subdirección de Investigación en Salud Pública. Instituto Nacional de Salud, Bogotá, Colombia.

Daniela Salas (D)

Grupo de Enfermedades Transmitidas por Vectores y Zoonosis, Instituto Nacional de Salud, Bogotá, Colombia.

Elizabeth Reyes Santamaría (E)

Departamento de Medicina interna y Departamento de Medicina crítica y cuidados intensivos. Hospital Universitario Fundación Santa Fe de Bogotá, Colombia.

Solmara Bello (S)

Grupo de Microbiología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Angélica Rico (A)

Grupo de Virología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.
Grupo de Enfermedades Transmisibles Prevenibles por Vacunación en Salud, Dirección de Vigilancia y Análisis del Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Lissethe Pardo (L)

Grupo de Virología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Edgar Parra (E)

Grupo de Patología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Karina Rodriguez (K)

Grupo de Microbiología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Zonía Alarcon (Z)

Grupo de Microbiología, Subdirección de Investigación en Salud Pública. Instituto Nacional de Salud, Bogotá, Colombia.

Angela Patricia Guerra Vega (AP)

Grupo de Parasitología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Mayra A Porras (MA)

Grupo de Virología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Sergio Yebrail Gomez-Rangel (SY)

Grupo de Virología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Carolina Duarte (C)

Grupo de Microbiología, Subdirección Laboratorio Nacional de Referencia. Dirección de Redes en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.

Jaime Moreno (J)

Grupo de Microbiología, Subdirección de Investigación en Salud Pública. Instituto Nacional de Salud, Bogotá, Colombia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH